Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Klaus R. Herrlinger"'
Autor:
Jörg Hofmann, Stephanie Kramer, Klaus R. Herrlinger, Kathrin Jeske, Martin Kuhns, Sabrina Weiss, Rainer G. Ulrich, Detlev H. Krüger
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 4, Pp 1234-1237 (2021)
We report molecular evidence of Tula virus infection in an immunocompetent patient from Germany who had typical signs of hantavirus disease. Accumulating evidence indicates that Tula virus infection, although often considered nonpathogenic, represent
Externí odkaz:
https://doaj.org/article/72c4847cfcfc497681fe345cadd39f4c
Autor:
Klaus R. Herrlinger, Eduard F. Stange
Publikováno v:
MMW - Fortschritte der Medizin. 164:67-69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef227653a41f8b0e6bb9b5f7a502c0c5
https://doi.org/10.1007/s15006-022-2176-1
https://doi.org/10.1007/s15006-022-2176-1
Autor:
Francis Maren Konermann, Nele Gessler, Peter Wohlmuth, Jürgen Behr, Johannes Feldhege, Christian Glöckner, Melanie A Gunawardene, Klaus R. Herrlinger, Thomas Hölting, Ulrich-Frank Pape, Niels Reinmuth, Axel Stang, Sara Sheikhzadeh, Dirk Arnold, Claas Wesseler
Publikováno v:
Oncology Research and Treatment.
Introduction: SARS-CoV-2 infected patients with cancer have a worse outcome including a significant higher mortality, compared to non-cancer patients. However, limited data are available regarding in-hospital mortality during the Omicron phase of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4377ce82baa79e9ec1aa8b35550f364
https://doi.org/10.1159/000529788
https://doi.org/10.1159/000529788
Autor:
Klaus, R Herrlinger, Eduard F, Stange
Publikováno v:
MMW Fortschritte der Medizin. 164(21-22)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c600f1a93b3bf0f90d0aee59ad7f7b9f
https://pubmed.ncbi.nlm.nih.gov/36510076
https://pubmed.ncbi.nlm.nih.gov/36510076
Autor:
Nicolas Feltgen, Thomas Ach, Focke Ziemssen, Carolin Sophie Quante, Oliver Gross, Alaa Din Abdin, Sabine Aisenbrey, Martin C. Bartram, Marcus Blum, Claudia Brockmann, Stefan Dithmar, Wilko Friedrichs, Rainer Guthoff, Lars-Olof Hattenbach, Klaus R. Herrlinger, Susanne Kaskel-Paul, Ramin Khoramnia, Julian E. Klaas, Tim U. Krohne, Albrecht Lommatzsch, Sabine Lueken, Mathias Maier, Lina Nassri, Thien A. Nguyen-Dang, Viola Radeck, Saskia Rau, Johann Roider, Dirk Sandner, Laura Schmalenberger, Irene Schmidtmann, Florian Schubert, Helena Siegel, Martin S. Spitzer, Andreas Stahl, Julia V. Stingl, Felix Treumer, Arne Viestenz, Joachim Wachtlin, Armin Wolf, Julian Zimmermann, Marc Schargus, Alexander K. Schuster
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 17; Pages: 5101
Journal of Clinical Medicine (17), 5101 (2022). doi:10.3390/jcm11175101
Journal of Clinical Medicine (17), 5101 (2022). doi:10.3390/jcm11175101
Journal of Clinical Medicine (17), 5101 (2022). doi:10.3390/jcm11175101
Published by MDPI, Basel
Published by MDPI, Basel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec708e401b7547aadec6489b06c25680
https://doi.org/10.3390/jcm11175101
https://doi.org/10.3390/jcm11175101
Autor:
Kathrin Jeske, Stephanie Kramer, Detlev H. Krüger, Sabrina Weiss, Rainer G. Ulrich, Jörg Hofmann, Klaus R Herrlinger, Martin Kuhns
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 27, Iss 4, Pp 1234-1237 (2021)
Emerging Infectious Diseases, Vol 27, Iss 4, Pp 1234-1237 (2021)
We report molecular evidence of Tula virus infection in an immunocompetent patient from Germany who had typical signs of hantavirus disease. Accumulating evidence indicates that Tula virus infection, although often considered nonpathogenic, represent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37843f3ab8f6326ee088039d55e1aae0
https://pubmed.ncbi.nlm.nih.gov/33754997
https://pubmed.ncbi.nlm.nih.gov/33754997
Autor:
Maureen J Koslowski, Irmgard Kübler, Mathias Chamaillard, Elke Schaeffeler, Walter Reinisch, Guoxing Wang, Julia Beisner, Alexander Teml, Laurent Peyrin-Biroulet, Stefan Winter, Klaus R Herrlinger, Paul Rutgeerts, Séverine Vermeire, Rachel Cooney, Klaus Fellermann, Derek Jewell, Charles L Bevins, Matthias Schwab, Eduard F Stange, Jan Wehkamp
Publikováno v:
PLoS ONE, Vol 4, Iss 2, p e4496 (2009)
Reduced expression of Paneth cell antimicrobial alpha-defensins, human defensin (HD)-5 and -6, characterizes Crohn's disease (CD) of the ileum. TCF-4 (also named TCF7L2), a Wnt signalling pathway transcription factor, orchestrates Paneth cell differe
Externí odkaz:
https://doaj.org/article/6837cf568a854f24b2bbe8a2472f4905
Autor:
Tobias Keck, Klaus R. Herrlinger, Siegbert Faiss, Florian Lordick, Thomas Mansky, Thilo Welsch
Publikováno v:
Visceral Medicine. 33:148-152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c4dcb0e64724083597f3d72f50effe
https://doi.org/10.1159/000467970
https://doi.org/10.1159/000467970
Autor:
Tobias Keck, Klaus R. Herrlinger
Publikováno v:
Volume and Quality in Visceral Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a93659157c0d4b6b2e484042d15b3ac7
https://doi.org/10.1159/000470894
https://doi.org/10.1159/000470894
Autor:
Walter, Reinisch, Sieglinde, Angelberger, Wolfgang, Petritsch, Olga, Shonova, Milan, Lukas, Simon, Bar-Meir, Alexander, Teml, Elke, Schaeffeler, Matthias, Schwab, Karin, Dilger, Roland, Greinwald, Ralph, Mueller, Eduard F, Stange, Klaus R, Herrlinger, Shmuel, Odes
Publikováno v:
Gut. 59:752-759
The aim of the study was to compare azathioprine versus mesalazine tablets for the prevention of clinical recurrence in patients with postoperative Crohn's disease (CD) with moderate or severe endoscopic recurrence.This was a 1 year, double-blind, do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b60efd000b04e34278ed77cf6ef49bd
https://doi.org/10.1136/gut.2009.194159
https://doi.org/10.1136/gut.2009.194159